WebLower-dose fluocinolone acetonide (Iluvien, Alimera Sciences) was most effective in patients with diabetic macular edema (DME) who had the disease for 3 years or more, according to a recent analysis of the data from the 36-month FAME study, presented by Andrew N. Antoszyk, MD, at ARVO. 1 The FAME study consisted of two identical, double masked, … Web然而,与单纯药物. 《新英格兰医学杂志》(New England Journal of Medicine)8月28日发表且同时在欧洲心脏病学会(ESC)2012年会上公布的FAME 2研究结果显示,对于具有至少1处生理明显病变的稳定型冠状动脉疾病患者,采用血流储备分数(FFR)指导经皮冠状动脉 …
FAME: 36-Month Results Support Efficacy of Fluocinolone …
Webfor the FAME Study Investigators * The investigators participating in the Fractional Flow Reserve versus Angiography for Multivessel … WebJun 5, 2024 · FAME2試験の5年追跡の結果がパリで開催されたPCR2024で発表され、NEJM誌に同時掲載された。FAME2試験は、PCI施行予定の安定冠動脈疾患において、FFR値0.8以下で定義される機能的虚血を有する場合に、PCI+至適薬物治療を行った場合と、至適薬物治療のみの場合をランダマイズし比較した研究である。 smallest district of jharkhand
Five-Year Outcomes with PCI Guided by Fractional Flow Reserve
WebNov 4, 2024 · In FAME 2, a trial that was stopped early, FFR-guided PCI plus optimal medical therapy was superior to medical therapy alone in patients with stable ischemic … WebFeb 4, 2014 · FAME II study The FAME II multicentre randomised controlled trial was conducted in 28 sites in Europe and North America and enrolled 1220 patients (De Bruyne et al. 2012; Fearon et al. 2013). Recruitment was from May 2010 to January 2012, at which point the trial was stopped because of a highly significant difference in the primary end … WebJul 5, 2024 · In contrast to FAME, FAME 2 focused on patients with FFR ≤0.80, comparing PCI to OMT alone. PCI yielded an 8% ARR of the primary endpoint, driven primarily by a reduction in urgent revascularizations. ... Patients with FFR >0.8 were not part of the randomized element of the study; they were treated with OMT alone; Optimal medical … songlifty